Key result
Pre-existing chronic HF is not linked to higher in-hospital mortality in cardiogenic shock.
Why the study?
Data are lacking on whether a pre-existing history of chronic heart failure contributes significantly to the heterogeneity of cardiogenic shock presentation, management, and prognosis.
Does a pre-existing history of chronic heart failure impact in-hospital mortality in patients presenting with cardiogenic shock?
Cohort (n=772)
Yes
Does a pre-existing history of chronic heart failure impact in-hospital mortality in patients presenting with cardiogenic shock?
In patients with cardiogenic shock, a pre-existing history of chronic heart failure is associated with a higher risk profile and significantly increased in-hospital all-cause mortality compared to new-onset heart failure.
Pre-existing chronic HF is not independently linked to higher cardiogenic shock mortality; leaves open its unadjusted prognostic role and need for validation.
There is a large heterogeneity among patients presenting with cardiogenic shock (CS). It is crucial to better apprehend this heterogeneity in order to adapt treatments and improve prognoses in these severe patients. Notably, the presence (or absence) of a pre-existing history of chronic heart failure (CHF) at time of CS onset may be a significant part of this heterogeneity, and data focusing on this aspect are lacking. We aimed to compare CS patients with new-onset HF to those with worsening CHF in the multicenter FRENSHOCK registry. Altogether, 772 CS patients were prospectively included: 433 with a previous history of CHF and 339 without. Worsening CHF patients were older (68 +/− 13.4 vs. 62.7 +/− 16.2, p < 0.001) and had a greater burden of extra-cardiac comorbidities. At admission, acute myocardial infarction was predominantly observed in the new-onset HF group (49.9% vs. 25.6%, p < 0.001). When focusing on hemodynamic parameters, worsening CHF patients showed more congestion and higher ventricular filling pressures. Worsening CHF patients experienced higher in-hospital all-cause mortality (31.3% vs. 24.2%, p = 0.029). Our results emphasize the great heterogeneity of the patients presenting with CS. Worsening CHF patients had higher risk profiles, and this translated to a 30% increase in in-hospital all-cause mortality. The heterogeneity of this population prompts us to better determine the phenotype of CS patients to adapt their management.
No takes yet. Share an insight, caveat, or question.
Schurtz et al. (2022) conducted a cohort in Cardiogenic shock (n=772). Pre-existing history of chronic heart failure (worsening CHF) vs. New-onset heart failure (no previous history) was evaluated on In-hospital all-cause mortality (OR 1.051, 95% CI 0.680-1.624, p=0.823). A pre-existing history of chronic heart failure in cardiogenic shock patients was not independently associated with higher in-hospital mortality after multivariate adjustment (OR 1.051, p=0.823).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: